Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04504201 · ClinicalTrials.gov registry record

Patient-centered Communication About Healthy Weight in Early Breast Cancer

A clinical trial of Breast Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
39
Enrollment target
1
Study location

NCT04504201 is a study of Breast Cancer that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 39 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04504201, a study of Breast Cancer, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
39 participants
Enrollment target
1
Study location

Study Summary

Comorbidities in breast cancer survival account for 49% of overall survival difference between black and white women. Many obesity-related comorbidities disproportionately affect black women, therefore pointing to a need to address obesity related comorbidities in survival disparities in early breast cancer patients. This study tinvestigates how messages and messaging about healthy weight can be tailored for racially diverse breast cancer survivors with obesity in order to ensure that clinic-based communications between patients and their oncology provider are patient-centered and culturally sensitive.

Conditions Studied

Interventions

  • OTHER Focus Group

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2020-06-15
Est. Completion 2020-09-29

What the Registry Record Tells You About NCT04504201

The ClinicalTrials.gov registry entry for NCT04504201 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Focus Group is the first listed.

NCT04504201 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04504201 about?

NCT04504201 is a clinical study titled "Patient-centered Communication About Healthy Weight in Early Breast Cancer". Comorbidities in breast cancer survival account for 49% of overall survival difference between black and white women. Many obesity-related comorbidities disproportionately affect black women, therefore pointing to a need to address obesity related comorbidities in survival disparities in early breas...

What is the current status of trial NCT04504201?

This trial is currently completed. The enrollment target is 39 participants. The study started on 2020-06-15. Estimated completion is 2020-09-29.

What conditions does trial NCT04504201 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT04504201?

The interventions under investigation include: Focus Group (OTHER).

Who is sponsoring clinical trial NCT04504201?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04504201 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.